Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vireo Growth ( (TSE:VREO) ) has shared an update.
On October 29, 2025, Vireo Growth Inc. announced a comprehensive settlement agreement with Verano Holdings Corp., resolving all outstanding litigation matters between the two companies. The settlement, valued at approximately US$10 million, includes the acquisition of real estate assets and US$1 million in cash for Vireo, marking the end of a complex legal chapter and allowing both companies to focus on their strategic priorities.
The most recent analyst rating on (TSE:VREO) stock is a Hold with a C$0.55 price target. To see the full list of analyst forecasts on Vireo Growth stock, see the TSE:VREO Stock Forecast page.
More about Vireo Growth
Vireo Growth Inc., founded in 2014, is a pioneering medical cannabis company focused on building a disciplined, strategically aligned platform within the industry. The company emphasizes a strong local market focus while leveraging a national portfolio, committing to hiring industry leaders and deploying capital and talent effectively. Vireo operates with a long-term mindset and a commitment to its customers, employees, shareholders, and communities.
YTD Price Performance: 7.41%
Average Trading Volume: 78,901
Technical Sentiment Signal: Buy
Current Market Cap: C$926.3M
See more insights into VREO stock on TipRanks’ Stock Analysis page.